181
Views
19
CrossRef citations to date
0
Altmetric
Review

Estimating the short-term clinical and economic benefits of smoking cessation: do we have it right?

, &
Pages 257-264 | Published online: 09 Jan 2014

References

  • Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ328(7455), 1519 (2004).
  • Feenstra TL, Hamberg-van Reenen HH, Hoogenveen RT, Rutten-van Molken MP. Cost–effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study. Value Health8(3), 178–190 (2005).
  • Hall SM, Lightwood JM, Humfleet GL, Bostrom A, Reus VI, Munoz R. Cost–effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation. J. Behav. Health Serv. Res.32(4), 381–392 (2005).
  • Ronckers ET, Groot W, Ament AJ. Systematic review of economic evaluations of smoking cessation: standardizing the cost–effectiveness. Med. Decis. Making25(4), 437–448 (2005).
  • Javitz HS, Swan GE, Zbikowski SM et al. Cost–effectiveness of different combinations of bupropion SR dose and behavioral treatment for smoking cessation: a societal perspective. Am. J. Manag. Care10(3), 217–226 (2004).
  • Song F, Raftery J, Aveyard P, Hyde C, Barton P, Woolacott N. Cost–effectiveness of pharmacological interventions for smoking cessation: a literature review and a decision analytic analysis. Med. Decis. Making22(5 Suppl.), S26–S37 (2002).
  • Cromwell J, Bartosch WJ, Fiore MC, Hasselblad V, Baker T. Cost–effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. JAMA278(21), 1759–1766 (1997).
  • Wasley MA, McNagny SE, Phillips VL, Ahluwalia JS. The cost–effectiveness of the nicotine transdermal patch for smoking cessation. Prev. Med.26(2), 264–70 (1997).
  • Tsevat J. Impact and cost–effectiveness of smoking interventions. Am. J. Med.93(1A), 43S–47S (1992).
  • Raw M, McNeill A, Watt J, Raw D. National smoking cessation services at risk. BMJ323(7322), 1140–1141 (2001).
  • Curry SJ, Keller PA, Orleans CT, Fiore MC. The role of health care systems in increased tobacco cessation. Annu. Rev. Public Health29, 411–428 (2008).
  • Henry RC, Ogle KS, Snellman LA. Preventive medicine: physician practices, beliefs, and perceived barriers for implementation. Fam. Med.19(2), 110–113 (1987).
  • Kenfield SA, Stampfer MJ, Rosner BA, Colditz GA. Smoking and smoking cessation in relation to mortality in women. JAMA299(17), 2037–2047 (2008).
  • Gourlay SG, Benowitz NL. The benefits of stopping smoking and the role of nicotine replacement therapy in older patients. Drugs Aging.9(8), 23 (1996).
  • Lightwood J. The economics of smoking and cardiovascular disease. Prog. Cardiovasc. Dis.46(1), 39–78 (2003).
  • Kawachi I, Colditz GA, Stampfer MJ et al. Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women. Arch. Intern. Med.154(2), 169–175 (1994).
  • Ockene JK, Kuller LH, Svendsen KH, Meilahn E. The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention Trial (MRFIT). Am. J. Public Health80(8), 954–958 (1990).
  • Wannamethee SG, Shaper AG, Whincup PH, Walker M. Smoking cessation and the risk of stroke in middle-aged men. JAMA274(2), 155–160 (1995).
  • Twardella D, Kupper-Nybelen J, Rothenbacher D, Hahmann H, Wusten B, Brenner H. Short-term benefit of smoking cessation in patients with coronary heart disease: estimates based on self-reported smoking data and serum cotinine measurements. Eur. Heart J.25(23), 2101–2108 (2004).
  • Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA290(1), 86–97 (2003).
  • Suskin N, Sheth T, Negassa A, Yusuf S. Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction. J. Am. Coll. Cardiol.37(6), 1677–1682 (2001).
  • Will JC, Galuska DA, Ford ES, Mokdad A, Calle EE. Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study. Int. J. Epidemiol.30(3), 540–546 (2001).
  • Brinton LA, Schairer C, Haenszel W et al. Cigarette smoking and invasive cervical cancer. JAMA255(23), 3265–3269 (1986).
  • Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet370(9589), 765–773 (2007).
  • Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am. J. Respir. Crit. Care Med.161(2 Pt 1), 381–390 (2000).
  • Moller AM, Villebro N, Pedersen T, Tonnesen H. Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet359(9301), 114–117 (2002).
  • Frick WG, Seals RR Jr. Smoking and wound healing: a review. Tex. Dent. J.111(6), 21–23 (1994).
  • Jorgensen LN, Kallehave F, Christensen E, Siana JE, Gottrup F. Less collagen production in smokers. Surgery123(4), 450–455 (1998).
  • Theadom A, Cropley M. Effects of preoperative smoking cessation on the incidence and risk of intraoperative and postoperative complications in adult smokers: a systematic review. Tob. Control15(5), 352–358 (2006).
  • Baumeister SE, Schumann A, Meyer C, John U, Volzke H, Alte D. Effects of smoking cessation on health care use: is elevated risk of hospitalization among former smokers attributable to smoking-related morbidity? Drug Alcohol Depend.88(2–3), 197–203 (2007).
  • Martinson BC, O’Connor PJ, Pronk NP, Rolnick SJ. Smoking cessation attempts in relation to prior health care charges: the effect of antecedent smoking-related symptoms? Am. J. Health Promot.18(2), 125–132 (2003).
  • Wagner EH, Curry SJ, Grothaus L, Saunders KW, McBride CM. The impact of smoking and quitting on health care use. Arch. Intern. Med.155(16), 1789–1795 (1995).
  • Fishman PA, Thompson E, Merikle E, Curry SJ. Changes in health care costs before and after smoking cessation. Nicotine Tob. Res.8(3), 393–401 (2006).
  • Barendregt JJ, Bonneux L, van der Maas PJ. The health care costs of smoking. N. Engl. J. Med.337(15), 1052–1057 (1997).
  • Fishman PA, Khan ZM, Thompson EE, Curry SJ. Health care costs among smokers, former smokers, and never smokers in an HMO. Health Serv. Res.38(2), 733–749 (2003).
  • Musich S, Faruzzi SD, Lu C, McDonald T, Hirschland D, Edington DW. Pattern of medical charges after quitting smoking among those with and without arthritis, allergies, or back pain. Am. J. Health Promot.18(2), 133–142 (2003).
  • Halpern MT. Impact of smoking status on workplace absenteeism and productivity. Tob. Control10(3), 233–8 (2001).
  • Wooden M, Bush R. Smoking cessation and absence from work. Prev. Med.24(5), 535–540 (1995).
  • Sindelar JL, Duchovny N, Falba TA, Busch SH. If smoking increases absences, does quitting reduce them? Tob. Control14(2), 99–105 (2005).
  • Burns ME, Rosenberg MA, Fiore MC. Use and employer costs of a pharmacotherapy smoking-cessation treatment benefit. Am. J. Prev. Med.32(2), 139–142 (2007).
  • Jason LA, Lesowitz T, Michaels M et al. A worksite smoking cessation intervention involving the media and incentives. Am. J. Community Psychol.17(6), 785–799 (1989).
  • Windsor RA, Lowe JB. Behavioral impact and cost analysis of a worksite self-help smoking cessation program. Prog. Clin. Biol. Res.293231–242 (1989).
  • Kristein MM. How much can businesses expect to profit from smoking cessation. Prev. Med.12(2), 358–81 (1983).
  • McGhan WF, Smith MD. Pharmacoeconomic analysis of smoking-cessation interventions. Am. J. Health Syst. Pharm.53(1), 45–52 (1996).
  • Nielsen K, Fiore MC. Cost–benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessation. Prev. Med.30(3), 209–16 (2000).
  • Javitz HS, Swan GE, Zbikowski SM et al. Return on investment of different combinations of bupropion SR dose and behavioral treatment for smoking cessation in a health care setting: an employer’s perspective. Value Health7(5), 535–543 (2004).
  • Warner KE, Smith RJ, Smith DG, Fries BE. Health and economic implications of a work-site smoking-cessation program: a simulation analysis. J. Occup. Environ. Med.38(10), 981–992 (1996).
  • Levy DE. Employer-sponsored insurance coverage of smoking cessation treatments. Am. J. Manag. Care12(9), 553–562 (2006).
  • Warner KE, Mendez D, Smith DG. The financial implications of coverage of smoking cessation treatment by managed care organizations. Inquiry41(1), 57–69 (2004).
  • Lightwood JM, Phibbs CS, Glantz SA. Short-term health and economic benefits of smoking cessation: low birth weight. Pediatrics104(6), 1312–1320 (1999).
  • Etzel RA. How environmental exposures influence the development and exacerbation of asthma. Pediatrics112(1 Pt 2), 233–239 (2003).
  • Hurley SF. Short-term impact of smoking cessation on myocardial infarction and stroke hospitalisations and costs in Australia. Med. J. Aust.183(1), 13–17 (2005).
  • Lightwood JM, Glantz SA. Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke. Circulation96(4), 1089–96 (1997).
  • McPhillips-Tangum C, Rehm B, Carreon R, Erceg CM, Bocchino C. Addressing tobacco in managed care: results of the 2003 survey. Prev. Chronic Dis.3(3), A87 (2006).
  • Boyle RG, Solberg LI, Magnan S, Davidson G, Alesci NL. Does insurance coverage for drug therapy affect smoking cessation? Health Aff. (Millwood)21(6), 162–168 (2002).
  • Foulds J. Effectiveness of smoking cessation initiatives. Smoking cessation services show good return on investment. BMJ324(7337), 608–609 (2002).
  • Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction99(1), 29–38 (2004).
  • Garvey AJ, Bliss RE, Hitchcock JL, Heinold JW, Rosner B. Predictors of smoking relapse among self-quitters: a report from the Normative Aging Study. Addict. Behav.17(4), 367–377 (1992).
  • Cohen SJ, Stookey GK, Katz BP, Drook CA, Smith DM. Encouraging primary care physicians to help smokers quit. A randomized, controlled trial. Ann. Intern. Med.110(8), 648–652 (1989).
  • Ebrahim S. Systematic review of cost–effectiveness research of stroke evaluation and treatment. Stroke30(12), 2759–2760 (1999).
  • Shibuya K, Ciecierski C, Guindon E, Bettcher DW, Evans DB, Murray CJ. WHO Framework Convention on Tobacco Control: development of an evidence based global public health treaty. BMJ327(7407), 154–157 (2003).
  • Avraham R, Camara KAD. The tragedy of the human commons. Cardozo Law Rev.29(2), 479–511 (2007).
  • Thomas P. The seven best tests. Harv. Health Lett.17(Suppl. 9), 1 (1992).
  • van Baal PH, Feenstra TL, Hoogenveen RT, de Wit GA, Brouwer WB. Unrelated medical care in life years gained and the cost utility of primary prevention: in search of a ‘perfect’ cost–utility ratio. Health Econ.16(4), 421–433 (2007).
  • Cohen JT, Neumann PJ, Weinstein MC. Does preventive care save money? Health economics and the presidential candidates. N. Engl. J. Med.358(7), 661–663 (2008).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.